| Cover | Jun. 25, 2024 |
| Cover [Abstract] | |
| Document Type | 8-K/A |
| Amendment Flag | true |
| Amendment Description | Explanatory Note |
| Document Period End Date | Jun. 25, 2024 |
| Entity File Number | 001-40890 |
| Entity Registrant Name | AUGMEDIX, INC. |
| Entity Central Index Key | 0001769804 |
| Entity Tax Identification Number | 83-3299164 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 111 Sutter Street |
| Entity Address, Address Line Two | Suite 1300 |
| Entity Address, City or Town | San Francisco |
| Entity Address, State or Province | CA |
| Entity Address, Postal Zip Code | 94104 |
| City Area Code | (888) |
| Local Phone Number | 669-4885 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, $0.0001 par value per share |
| Trading Symbol | AUGX |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | true |
| Elected Not To Use the Extended Transition Period | false |
